Concepedia

Zhengyang Wu

ZW

Statistics

Publications

9

Citations

249

H-Index

9

Active since

2019

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

University of Science and Technology of China

Zhengyang Wu is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2019–2022

9

Publications

9

Circular RNA hsa_circ_0000277 sequesters miR-4766-5p to upregulate LAMA1 and promote esophageal carcinoma progression

Peng Zhou, Zhengyang Wu, Wenguang Zhang et al. · Cell Death and Disease · 2021 · 63 citations · Full text

, , +17

Perilipin 5 deficiency promotes atherosclerosis progression through accelerating inflammation, apoptosis, and oxidative stress

Pengli Zhou, Min Li, Xinwei Han et al. · Journal of Cellular Biochemistry · 2019 · 32 citations

, , +17

Exploratory versus exploitative innovation: SME performance implications of managerial ties and empowering leadership in China

Zhengyang Wu, Xiaobao Peng · Asian Journal of Technology Innovation · 2020 · 32 citations · Full text

, , +10

Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer

Zhengyang Wu, Ying Bai, Jiaming Jin et al. · European Journal of Medicinal Chemistry · 2021 · 31 citations · Full text

, , +8

The Interaction Between lncRNA SNHG1 and miR-140 in Regulating Growth and Tumorigenesis via the TLR4/NF-κB Pathway in Cholangiocarcinoma

Zhen Li, Xin Li, Xiao Du et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2019 · 28 citations · Full text

, , +17

1–5 of 9